These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38093164)

  • 1. ASO Author Reflections: Nationwide Experience on Locally Advanced Pancreatic Cancer Surgery After Induction Chemotherapy in the Netherlands: A Stepping Stone for the PREOPANC-4 Trial.
    Stoop TF; Seelen LWF; van 't Land FR; van Eijck CHJ; van Santvoort HC; Besselink MG;
    Ann Surg Oncol; 2024 Apr; 31(4):2658-2659. PubMed ID: 38093164
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer-Resection Cuts the Deal.
    Eshmuminov D; Aminjonov B; Palm RF; Lehmann K
    Ann Surg Oncol; 2023 Jul; 30(7):4429-4430. PubMed ID: 37074518
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Postoperative Chemotherapy After Neoadjuvant Therapy and Pancreatectomy for Pancreatic Cancer: Balancing Patient Physiology and Disease Biology.
    Kamarajah SK; Dahdaleh F
    Ann Surg Oncol; 2021 Oct; 28(11):6803-6804. PubMed ID: 33774772
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Prediction of the Chemotherapy Effect on the Prognosis of Locally Advanced Pancreatic Cancer.
    Tanaka M; Hackert T
    Ann Surg Oncol; 2023 Apr; 30(4):2409-2410. PubMed ID: 36209330
    [No Abstract]   [Full Text] [Related]  

  • 5. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
    Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
    Tsilimigras DI; Moris D; Pawlik TM
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):610-611. PubMed ID: 31087182
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Should we Stick our Neck Out for Pancreatic Neck Margins During Pancreaticoduodenectomy After Neoadjuvant Therapy?
    Schachner B; Kelly K; Merchant NB; Datta J
    Ann Surg Oncol; 2022 Sep; 29(9):6013-6014. PubMed ID: 35486265
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy Changes Body Composition Influencing Long-term Outcomes.
    Takaichi S; Tomimaru Y; Kobayashi S; Toya K; Sasaki K; Iwagami Y; Yamada D; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
    Ann Surg Oncol; 2023 Apr; 30(4):2469-2470. PubMed ID: 36567385
    [No Abstract]   [Full Text] [Related]  

  • 9. Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.
    Versteijne E; van Eijck CH; Punt CJ; Suker M; Zwinderman AH; Dohmen MA; Groothuis KB; Busch OR; Besselink MG; de Hingh IH; Ten Tije AJ; Patijn GA; Bonsing BA; de Vos-Geelen J; Klaase JM; Festen S; Boerma D; Erdmann JI; Molenaar IQ; van der Harst E; van der Kolk MB; Rasch CR; van Tienhoven G;
    Trials; 2016 Mar; 17(1):127. PubMed ID: 26955809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients.
    Olecki EJ; Gusani NJ
    Ann Surg Oncol; 2021 Jun; 28(6):3123. PubMed ID: 33616769
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.
    Mellon EA; Jin WH; Frakes JM; Centeno BA; Strom TJ; Springett GM; Malafa MP; Shridhar R; Hodul PJ; Hoffe SE
    Acta Oncol; 2017 Mar; 56(3):391-397. PubMed ID: 27885876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASO Author Reflections: Distal Pancreatectomy with Celiac Axis Resection for Locally Advanced Pancreatic Cancer-Patient Selection and Surgical Experience are Key.
    Klompmaker S; Besselink MG
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):828-829. PubMed ID: 30456669
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.
    Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H
    Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASO Author Reflections: Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer.
    Tomioka A; Uchiyama K
    Ann Surg Oncol; 2021 Jul; 28(7):3798-3799. PubMed ID: 33236253
    [No Abstract]   [Full Text] [Related]  

  • 15. Primarily resectable pancreatic adenocarcinoma - to operate or to refer the patient to an oncologist?
    Piątek M; Kuśnierz K; Bieńkowski M; Pęksa R; Kowalczyk M; Nawrocki S
    Crit Rev Oncol Hematol; 2019 Mar; 135():95-102. PubMed ID: 30819452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASO Author Reflections: Novel Evidence on Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer with Arterial Involvement.
    Ikenaga N; Miyasaka Y; Ohtsuka T; Nakamura M
    Ann Surg Oncol; 2023 Jan; 30(1):203-204. PubMed ID: 36131116
    [No Abstract]   [Full Text] [Related]  

  • 17. [A Successful Case of Locally Advanced Pancreatic Cancer Undergoing Curative Total Pancreatectomy after Chemotherapy].
    Terashima T; Kawamoto S; Maekawa K; Shinozaki N; Kuroki N
    Gan To Kagaku Ryoho; 2020 Apr; 47(4):688-690. PubMed ID: 32389985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer.
    Alva-Ruiz R; Truty MJ
    Ann Surg Oncol; 2022 Mar; 29(3):1592-1593. PubMed ID: 34705142
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: A Novel Classification System to Predict Outcome in Solid Pseudopapillary Tumor of the Pancreas.
    Yang F; Fu D
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):757-758. PubMed ID: 32424590
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to Comment on "Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer".
    Rangelova E; Orsini N; Del Chiaro M
    Ann Surg; 2019 Dec; 270(6):e139-e141. PubMed ID: 31730557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.